All results

1 results for tests

• ATB200-08

  This is a Phase 3, open-label, multicenter study to evaluate the safety, efficacy, PK, PD, and immunogenicity of cipaglucosidase alfa/miglustat treatment in…

  Ages

  N/A - 17 Years

  Sexes

  All